Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Active Tuberculosis Infection in Transplant Recipients: A Systematic Review and Meta-Analysis Publisher Pubmed



Mamishi S1, 2 ; Pourakbari B1 ; Moradzadeh M1 ; Van Leeuwen WB3 ; Mahmoudi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Infectious Disease Research Center, Tehran University of Medical Science, Tehran, Iran
  2. 2. Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Innovative Molecular Diagnostics, University of Applied Sciences Leiden, Leiden, Netherlands

Source: Microbial Pathogenesis Published:2020


Abstract

Introduction: Tuberculosis (TB) is considered as a serious complication of organ transplant; therefore, the detection and appropriate treatment of active TB infection is highly recommended for the reduction of mortality in the future. The aim of this review was to conduct a systematic review and meta-analysis assessing the prevalence of active TB infection in transplant recipients (TRs). Material and methods: Electronic databases, including MEDLINE (via PubMed), SCOPUS and Web of Science were searched up to December 24, 2017. The prevalence of active TB was estimated using the random effects meta-analysis. Heterogeneity was evaluated by subgroup analysis. Data were analyzed by STATA version 14. Results: The pooled prevalence of post-transplant active TB was estimated 3% [95% CI: 2–3]. The pooled prevalence of active TB in different transplant forms was as follows: renal,3% [95% CI: 2–4]; stem cell transplant (SCT), 1% [95% CI: 0–3]; lung, 4% [95% CI: 2–6]; heart, 3% [95% CI: 2–4]; liver, 1% [95% CI: 1], and hematopoietic stem cell transplant (HSCT), 2% [95% CI: 1–3]. The prevalence of different clinical presentations of TB was as follows: pulmonary TB (59%; 95% CI: 54–65), extra pulmonary TB (27%; 95% CI: 21–33), disseminated TB (15%; 95% CI: 12–19) and miliary TB (8%; 95% CI: 4–13). The pooled prevalence of different diagnostic tests was as follows: chest X-ray, 57% [95% CI, 46–67]; culture, 56% [95% CI, 45–68]; smear, 49% [95% CI, 40–58]; PCR, 43% [95% CI, 40–58]; histology, 26% [95% CI, 20–32], and tuberculin skin test, 19% [95% CI, 10–28]. Conclusion: A high suspicion level for TB, the early diagnosis and the prompt initiation of therapy could increase the survival rates among SOT patients. Overall, renal and lung TRs appear to have a higher predisposition for acquiring TB than other type of recipients. Monitoring of the high-risk recipients, prompt diagnosis, and appropriate treatment are required to manage TB infection among TRs especially in endemic areas. © 2019 Elsevier Ltd
Other Related Docs
20. The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis, International Journal for Vitamin and Nutrition Research (2025)
30. Vitamin D Receptor Gene Polymorphisms and the Risk of Metabolic Syndrome (Mets): A Meta-Analysis, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
44. Prevalence of Tb/ Hiv Co-Infection in Iran: A Systematic Review and Meta-Analysis, Annali di Igiene Medicina Preventiva e di Comunita (2019)